Peptidream Inc., of Tokyo, reported that it inked an agreement with Shionogi and Co. Ltd., of Osaka, Japan, for a nonexclusive license of Peptidream's Peptide Discovery Platform System (PDPS). Under the terms, Shionogi will pay Peptidream an undisclosed up-front payment and additional technology access payments, plus Peptidream will be eligible to receive payments based on the achievement of particular predetermined development milestones for any constrained peptides and/or small molecules discovered via the PDPS technology.